In our model, we believe that the downregulation of GCNT2 is important for the loss of I-branched glycans in melanoma cells and perhaps even for the increase in extended i-linear polyLacNAcs through less donor sugar competition between B3GNT and GCNT2. The gene discussed is GCNT2; the disease is melanoma.